Navigation Links
Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents
Date:5/12/2008

ysicians' ability to choose the most suitable stent for each patient and the long term benefits provided for each individual vessel and lesion.

The Presillion comes in diameters ranging from 2.5-4.0 mm. and in lengths ranging from 8-32 mm. The Presillion stent system and can be used to treat various lesion types: de novo, restenotic lesions, total occlusions, bifurcations, and acute myocardial infarction.

Medinol continues setting new standards in the stenting industry through design innovation and advance technology manufacturing methods. Medinol is constantly enhancing its technology and producing stenting solutions for: coronary and vascular systems, bifurcation stenting and biliary stenting. Medinol is currently developing advanced technology stents and additional therapeutic solutions for the treatment of vascular disease that will be introduced to the market in the near future.

Contact:

Tamar Hadar

Senior Director, Global Sales & Marketing

Medinol Ltd.

Office: +972-3-7679000 ext. 256

Tamar.Hadar@MEDINOL.COM


'/>"/>
SOURCE Medinol Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device
2. Strykers Biotech Division Receives FDA Warning Letter
3. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
4. Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
5. Genta Receives Key Patent Related to Oral Gallium Compound G4544
6. QMed, Inc. Receives 2-Year Extension of Medicare Coordinated Care Demonstration Project by CMS
7. Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium
8. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
9. DermaGen AB Receives Over 1 Million Euros From a New Share Issue
10. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
11. Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ewswire/ -- FluoroPharma Inc., a company developin...sitron Emission Tomography,(PET) market, announced...orine-18 labeled tracer for myocardial perfusion i...lar product to complete Phase I clinical,developme...sess the blood flow in the,heart (myocardial perfu...
(Date:7/23/2008)...23 /- InCode BioPharmaceutics, Inc.,...nced preclinical test,results demonstrating the ut...reatment of the rare chronic blood disorder paroxy...results will be presented at the XXII,Internationa...mber 28,2008., The only treatment currently avai...
(Date:7/23/2008)...ND-Enabling Work with Protein Therapeutics that ... System, CAMBRIDGE, Mass., July 23 /... initiated a corporate growth plan with the,appoin... officer and the,establishment of its headquarters...f Emlen, M.D., a co-founder of the company who rem...
(Date:7/22/2008)...sults from a multi-center 293-patient European, t... Exchange Symbol: CYT, MONTREAL, July 22 /PRNewsw...e global leader in cryotherapy products to treat c...reviously presented from three,European study cent...(R),were published earlier today in the Journal o...
Breaking Medicine Technology:FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Access Highlighted in Recent BusinessWeek Article 498 1Access Highlighted in Recent BusinessWeek Article 498 2Prescription labels geared toward pharmacies not patients 982 1Prescription labels geared toward pharmacies not patients 982 2Scientists fear rare dolphin driven to extinction by human activities 345 1Scientists fear rare dolphin driven to extinction by human activities 345 2IVCC launches groundbreaking insecticide projects with Bayer and Syngenta 978 1IVCC launches groundbreaking insecticide projects with Bayer and Syngenta 978 2
(Date:7/25/2008)...ncial results -, LAVAL, QC, July 25 /PRNewswire-F...) today announced that it will host a conference c...ss its second quarter 2008,financial results. Labo...l,results via news release at approximately 7:00 a...by telephone, dial 416-646-3095 or,1-800-814-4859....
(Date:7/25/2008)...stCall/ -- Thoratec,Corporation (Nasdaq: THOR ) a...ry support therapies to save, support and restore ...t its operating results for the second,quarter and... 31., The company will hold a conference call to ...ties to all interested parties at 1:30 p.m.,Pacif...
(Date:7/25/2008)...unction, increases asthma risk, studies find, ,... clean, fresh-smelling home may actually be bad fo...and air freshening products you use. , Recent r...s or air fresheners that contain a certain volatil...ne (1,4 DCB), can reduce lung function by 4 percen...
(Date:7/25/2008)... Society for Gastrointestinal Endoscopy (ASGE) has... bariatric surgery patient. The rising prevalence ... surgical interventions led to a marked increase i... the U.S., from 13,365 in 1998 to 102,794 in 2003....ive patient and the postoperative patient, and app...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3
...nder affects learning have found that boys and gir...rent ways. However, they have suggested that thi...er their kids from co-educational to segregated sc...American educator Michael Gurian, at a conference ...
...co will kill a billion people this century, 10 tim... unless the countries take serious action to preve...re assuming that by putting one cigarette to your ...if you sniff-up someone else's smoke only once, yo...
...first manned mission to Mars, it has taken its fir...o you get rid of the body of a dead astronaut on a...the plug be pulled on a critically ill astronaut w...ngering the rest of the crew? Should NASA employ D...
...reveals the war veterans who have come back after ...nt. Due to the exposure to chemicals and other har...o brain regions that are closely linked to learnin...of the department of environmental health at the B...
Other Medicine News:Health News:Boys and Girls are Different by Nature and Learn in Different Ways 2Health News:1 Billion People to Be Killed by Smoking 2Health News:NASA Gets Ready To Address Tough Questions 2Health News:NASA Gets Ready To Address Tough Questions 3Health News:Gulf War Veterans Exhibit Memory Impairment 2
...ut patients negative for antinuclear antibodies, w...c diseases such as Systemic lupus erythematosus (L...disease, progressive systemic sclerosis, scleroder...henomenon. They can also be used in conjunction wi...
The PANBIO Inc. Indirect Fluorescence Assay (IFA) for IgG Antinuclear Antibody (ANA) HEp2 is intended for the qualitative and semi-quantitative detection of IgG (Immunoglobulin G) antinuclear antibod
The VerifyNow Clopidogrel Assay measures changes in platelet function in response to patients taking Clopidogrel (Plavix). It uses a specific activator for the P2Y12 pathway, which clopidogrel inhibi
The Wide Angle Twin Mag NP combines the performance of two instruments to deliver unequalled power and versatility into the hands of eye care professionals.
Medicine Products: